Attitudes of prostate cancer patients towards the diagnosis and treatment of their disease: Findings from a multinational survey

Current Medical Research and Opinion

Volumn 23, Issue 9, 2007, Pages 2107-2116

  Hardy, Claire ^a   Penn, Samantha ^b   Morris, Thomas ^b  

^a Fast Forward Research Ltd   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Antiandrogen; Combined androgen blockade; Luteinising hormone releasing hormone agonist; Prostate cancer; Questionnaire

Indexed keywords

ANTIANDROGEN; BICALUTAMIDE; CYPROTERONE ACETATE; FLUTAMIDE; GONADORELIN AGONIST; GOSERELIN; LEUPRORELIN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER THERAPY; CONTROLLED STUDY; HEALTH SURVEY; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; METASTASIS; MONOTHERAPY; PATIENT ATTITUDE; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; ATTITUDE TO HEALTH; CLINICAL TRIAL; MIDDLE AGED; MULTICENTER STUDY; PATIENT EDUCATION; PROSTATE TUMOR; PSYCHOLOGICAL ASPECT;

AGED; ATTITUDE TO HEALTH; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 36048986028     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079907X223800     Document Type: Article

References (11)

1. Mason M. What implications do the tolerability profiles of antiandrogens and other commonly used prostate cancer treatments have on patient care? J Cancer Res Clin Oncol 2006;132(Suppl 13):27-35
2. Jenkins V, Fallowfield L, Saul J. Information needs of patients with cancer: results from a large study in UK cancer centres. Br J Cancer 2001;84:48-51
3. Davison BJ, Parker PA, Goldenberg SL. Patients' preferences for communicating a prostate cancer diagnosis and participating in medical decision-making. BJU Int 2004;93:47-51
4. Lloyd A, Penson D, Dewilde S, Kleinman L. Eliciting patient preferences for hormonal therapy options in the treatment of metastatic prostate cancer. Prostate Cancer Prostatic Dis 2007; e-pub ahead of print, doi:10.1038/sj.pcan. 4500992.
5. Litwin MS, Hays RD, Fink A, et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 1995;273:129-35
6. Madalinska JB, Essink-Bot ML, de Koning HJ, et al. Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer. J Clin Oncol 2001;19:1619-28
7. Clark JA, Inui TS, Silliman RA, et al. Patients' perceptions of quality of life after treatment for early prostate cancer. J Clin Oncol 2003;21:3777-84
8. Korfage IJ, Hak T, de Koning HJ, Essink-Bot ML. Patients' perceptions of the side-effects of prostate cancer treatment - a qualitative interview study. Soc Sci Med 2006;63:911-19
9. Clark JA, Rieker P, Propert KJ, Talcott JA. Changes in quality of life following treatment for early prostate cancer. Urology 1999;53:161-8
10. SEER Stat Fact Sheets - Cancer of the Prostate [online]. Available from http://seer.cancer.gov/statfacts/html/prost.html7statfacts_page=prost. html&x=2&y=11 [Accessed 18 Jun 2007]
11. AF Cancer Research UK. UK Prostate Cancer incidence statistics [online]. Available from http://info.cancerresearchuk.org/cancerstats/types/prostate/ incidence/ [Accessed 18 Jun 2007]